Releases & Statements
-
Feb 28, 2018
CVS-Aetna Merger Proposal Emblematic of Growing Arms Race to Consolidate, Control Consumer Access to Health Care, Prescription Drugs
House Judiciary Subcommittee Hearing on Drug Supply Chain Should Examine Increasingly Oligopolistic Health Care System, Efforts to Monopolize Prescription Drug Marketplace…Read More.
-
Feb 12, 2018
National LTC Pharmacy Group Praises Trump White House Report Targeting PBM “Lack of Transparency”
Report Says Policies to Disrupt PBM Oligopoly “Can Reduce the Price of Drugs Paid by Consumers”…Read More.
-
Jan 26, 2018
Senior Care Pharmacy Coalition Comments on Healthcare Choice and Competition
January 25, 2018 Via Electronic Submission: CompetitionRFI@hhs.gov John R. Graham Acting Assistant Secretary for Planning and Evaluation Department of Health and Human Services 200 Independence Avenue, S.W. Washington, D.C. 20201 Re: Response to RFI: Promoting Healthcare Choice and Competition Dear Mr. Graham: The Senior Care Pharmacy Coalition (SCPC) commends the office of the Assistant Secretary […]
-
Jan 24, 2018
Senior Care Pharmacy Coalition (SCPC) Slams PBM Industry Attempt to Hide Behind Non-Interference Clause to Sustain Anti-Competitive Price Gouging
National LTC Pharmacy Advocacy Group Says Congress Never Intended Clause to be Misused to Undermine Free-Market…Read More.
-
Jan 23, 2018
National LTC Pharmacy Group Urges CMS to Prohibit PBM Pharmacy Fees — Not Reform Them
SCPC Also Says Conceptual “Point of Sale” Policy Solution Not Effective for LTC Pharmacies, LTC Patients as Dually-Eligible Beneficiaries Constitute High Percentage of Patient Population; CMS Authorized to Act under Medicare Part D…Read More.
-
Dec 13, 2017
SCPC Outlines PBM Reforms Needed to Protect Consumers, Elderly Patients, LTC Pharmacies
Tells House Energy and Commerce Health Panel Medicare Part D Has Become Oligopolistic Market Benefitting Only PBMs and Their Conglomerates…Read More.
-
Dec 12, 2017
New Report on Prescription Drug Costs: PBMs “Rife with Potential Conflicts of Interest”
SCPC Praises Senate HELP Committee’s Ongoing Examination of Drug Costs, says “PBM Oligopoly Maintains Anti-Competitive Stranglehold on LTC Pharmacies and Patients Under Their Care”…Read More.
-
Dec 12, 2017
New SCPC Comments to FTC Detail Steps to Foster Competition in Pharmaceutical Pricing and Supply Chain
2017 Year-End Focus on Drug Pricing by Senate HELP, House Energy and Commerce Committees Demonstrate Ongoing Saliency of Examining PBM Market Manipulation…Read More.
-
Nov 28, 2017
National LTC Pharmacy Group Praises Proposed CMS Rule for Recognizing PBM Abuses, Proposing Ways to Stop Them
SCPC Also Lauds Implementation of 2016 CARA Bill Recognizing Essential Difference Between LTC and Retail Pharmacies…Read More.
View Archives
By Date
- March 2024 (4)
- February 2024 (1)
- November 2023 (3)
- October 2023 (1)
- September 2023 (2)
- August 2023 (4)
- July 2023 (4)
- June 2023 (1)
- March 2023 (2)
- January 2023 (1)
- December 2022 (1)
- October 2022 (4)
- July 2022 (1)
- June 2022 (3)